Liver Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Early warning score accurately predicts mortality risk in liver disease - Healio



Early warning score accurately predicts mortality risk in liver disease 
Healio
The National Early Warning Score accurately identified patients with chronic liver diseases at risk for death, admission to the intensive care unit or cardiac arrest within a 24-hour period, according to a recently published study. ?Hospitalized ...

 


In the middle of Dry January, researchers come out in support of moderate drinking - SowetanLIVE Sunday Wolrd



SowetanLIVE Sunday Wolrd
 
In the middle of Dry January, researchers come out in support of moderate drinking 
SowetanLIVE Sunday Wolrd
Overdoing it can also lead to health problems not health benefits says Davies, such as neurological and memory-related disorders, certain forms of cancer, heart disease and liver problems. However like Orrange he agrees that a little alcohol can be a ...

and more » 


Albireo to Receive More than $55 Million(1) in Nondilutive Cash ... - Markets Insider



Albireo to Receive More than $55 Million(1) in Nondilutive Cash ... 
Markets Insider
Elobixibat approved in Japan for the treatment of chronic constipation ?? Albireo innovation leads to world's first approved ileal bile acid transporter (...

and more » 


Managing Bone Disease in Adults with Eating Disorders - Medical News Bulletin



Medical News Bulletin
 
Managing Bone Disease in Adults with Eating Disorders 
Medical News Bulletin
After a thorough literature review, the causes of bone disease in patients with eating disorders seemed to be multifaceted and remained under investigation. It seems that some eating disorder patients already were predisposed to high risks for bone ...

and more » 


Pandion Therapeutics launches with $58M series A | FierceBiotech - FierceBiotech



Boston Business Journal
 
Pandion Therapeutics launches with $58M series A | FierceBiotech 
FierceBiotech
Pandion Therapeutics is working on localized treatments for autoimmune and inflammatory disease as a more effective and durable alternative to current systemic immunosuppressive therapies.
Biogen, Pfizer vets launch autoimmune disease startup backed by ... Boston Business Journal
Pandion raises $58M for its autoimmune platform inspired by the tumor microenvironment MedCity News

all 10 news articles » 


Flu kills third-grade Pike Road student - Montgomery Advertiser



Montgomery Advertiser
 
Flu kills third-grade Pike Road student 
Montgomery Advertiser
A Pike Road Schools student died of the flu Tuesday night, the school system superintendent confirmed Thursday. Third-grade Pike Road Elementary student Zainab Momin stayed home from school Tuesday with flu symptoms, said Pike Road Schools ...

and more » 


Pathology of Liver Diseases ? Gastroenterology, Healthcare, Healthcare Services, Therapeutic Area Industries - MilTech



Pathology of Liver Diseases ? Gastroenterology, Healthcare, Healthcare Services, Therapeutic Area Industries 
MilTech
The Pathology of Liver Diseases Report has been published. It provides updated in 2018 year analysis of industries from Gastroenterology, Healthcare, Healthcare Services, Therapeutic Area Markets. Pathology of Liver Diseases is a rapid reference ...

and more » 


Pancreatic Conference, Liver Disorders,Gastroenterology Meeting - pharmaphorum



Pancreatic Conference, Liver Disorders,Gastroenterology Meeting 
pharmaphorum
PULSUS Conferences invites all the participants from all over the world to attend ?3rd International Conference on Pancreatic Cancer and Liver Diseases? under the theme ?Making Life Better: Fight Against Pancreatic Cancer and Liver Diseases? during ...

 


In The Spotlight: Immuron Ltd. - Nasdaq.com - Nasdaq



In The Spotlight: Immuron Ltd. - Nasdaq.com 
Nasdaq
The American Depositary Shares of Immuron Limited have gained nearly 33% in the last 5 trading days. Immuron, an Australian biopharmaceutical.

and more » 


Arrowhead Pharmaceuticals, Inc. (ARWR) EPS Estimated At $-0.15 - Frisco Fastball



Frisco Fastball
 
Arrowhead Pharmaceuticals, Inc. (ARWR) EPS Estimated At $-0.15 
Frisco Fastball
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company has market cap of $449.37 million. The Company's pre-clinical stage medicines include ARO-HBV to treat chronic hepatitis B ...
Critical Contrast: Viking Therapeutics (VKTX) versus Arrowhead Pharmaceuticals (ARWR) The Ledger Gazette
Arrowhead Pharmaceuticals, Inc. (ARWR) Reaches $6.08 After 5.00% Up Move; Jackson Square Partners Has ... UtahHerald.com

all 79 news articles »